2ndVote Life Neutral Plus ETF
LYFE
LYFE was delisted on the 3rd of August, 2023.
12 hedge funds and large institutions have $1.24M invested in 2ndVote Life Neutral Plus ETF in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
0% more capital invested
Capital invested by funds: $1.24M → $1.24M (+$820)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$25K |
| 2 |
MFG
Mendota Financial Group
Madison,
Wisconsin
|
+$20.7K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$4.74K |
| 4 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
+$1.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$76.5K |
| 2 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
-$50K |
LYFE Hedge Fund Activity: Q2 2023 in Review
12 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in 2ndVote Life Neutral Plus ETF (LYFE) for Q2 2023, worth a combined $1.24M — up 0.07% from $1.24M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LYFE positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $25K. The largest seller was Citadel Advisors, cutting an estimated $76.5K.
- 12 institutional investors held 2ndVote Life Neutral Plus ETF (LYFE) as of Q2 2023, up from 11 in Q1 2023.
- Funds reported $1.24M of 2ndVote Life Neutral Plus ETF stock for Q2 2023, up 0.07% quarter-over-quarter.
- 1 fund opened new 2ndVote Life Neutral Plus ETF positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest 2ndVote Life Neutral Plus ETF buyer in Q2 2023 was UBS Group, an estimated $25K added.
- The largest 2ndVote Life Neutral Plus ETF seller in Q2 2023 was Citadel Advisors, an estimated $76.5K sold.
Based on aggregated 13F filings for Q2 2023.